Biofrontera Inc. Closes a $4.2 Million Senior Secured Convertible Note WOBURN, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization...

Global Drug Device Combination Products Market is expected to reach revenue of USD 389.7 Bn by 2033, at 9.3% CAGR: Dimension Market Research. New York, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Overview The Global Drug Device Combination Products Market is projected to reach USD 174.4 billion in 2024 which is further anticipated to reach USD...

Dyspepsia Treatment Market to advancement at a CAGR of 4.1% during 2022–2031, as demand for non-invasive treatment is growing | TMR Study Wilmington, Delaware, United States, March 11, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. – In 2021, the Global Dyspareunia Treatment Market size was worth US$ 689.0 Mn. Dyspareunia...